{"DataElement":{"publicId":"4888811","version":"1","preferredName":"Injection Site Induration Edema Occurrence Type","preferredDefinition":"The response regarding the degree of swelling/induration that occurs at the injection site of medication or vaccine.","longName":"INJ_SIT_SWEL_SEV_TYP","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"4182699","version":"1","preferredName":"Injection Site Induration Edema Occurrence","preferredDefinition":"The anatomic site at which a medication or a vaccine is injected._An instance of something happening, such as an event or incident._The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.  This is often associated with inflammation and infiltration of a neoplasm._Accumulation of an excessive amount of fluid in cells or intercellular tissues.","longName":"4182697v1.0:2234856v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"4182697","version":"1","preferredName":"Injection Site Induration Edema","preferredDefinition":"The anatomic site at which a medication or a vaccine is injected.:The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.  This is often associated with inflammation and infiltration of a neoplasm.:Accumulation of an excessive amount of fluid in cells or intercellular tissues.","longName":"C77680:C25534:C3002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Injection Site","conceptCode":"C77680","definition":"The anatomic site at which a medication or a vaccine is injected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Induration","conceptCode":"C25534","definition":"The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Edema","conceptCode":"C3002","definition":"Accumulation of an excessive amount of fluid in cells or intercellular tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F36DA8F6-1392-4BFF-E040-BB89AD435DA3","latestVersionIndicator":"Yes","beginDate":"2014-02-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-02-27","modifiedBy":"ONEDATA","dateModified":"2014-02-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F36DA8F6-13A0-4BFF-E040-BB89AD435DA3","latestVersionIndicator":"Yes","beginDate":"2014-02-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-02-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"MAY2013-01-01_02-26-14_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4888792","version":"1","preferredName":"Injection Site Induration Edema Type","preferredDefinition":"The anatomic site at which a medication or a vaccine is injected._The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.  This is often associated with inflammation and infiltration of a neoplasm._Accumulation of an excessive amount of fluid in cells or intercellular tissues._Something distinguishable as an identifiable class based on common qualities.","longName":"4888792v1.0","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Damage to skin or tissue","valueDescription":"Damage to skin or tissue","ValueMeaning":{"publicId":"4888751","version":"1","preferredName":"Damage to skin or tissue","longName":"4888751","preferredDefinition":"Damage to skin or tissue","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19ABEEEA-DACB-C2EF-E050-BB89AD43271C","latestVersionIndicator":"Yes","beginDate":"2015-06-29","endDate":null,"createdBy":"LUY","dateCreated":"2015-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19ACAF00-EA20-ED37-E050-BB89AD433698","beginDate":"2015-06-29","endDate":null,"createdBy":"LUY","dateCreated":"2015-06-29","modifiedBy":"ONEDATA","dateModified":"2015-06-29","deletedIndicator":"No"},{"value":"Could not perform normal activities","valueDescription":"Could not perform normal activities","ValueMeaning":{"publicId":"4888752","version":"1","preferredName":"Could not perform normal activities","longName":"4888752","preferredDefinition":"Could not perform normal activities","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19ABEEEA-DAEE-C2EF-E050-BB89AD43271C","latestVersionIndicator":"Yes","beginDate":"2015-06-29","endDate":null,"createdBy":"LUY","dateCreated":"2015-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19ACAF00-EA2A-ED37-E050-BB89AD433698","beginDate":"2015-06-29","endDate":null,"createdBy":"LUY","dateCreated":"2015-06-29","modifiedBy":"ONEDATA","dateModified":"2015-06-29","deletedIndicator":"No"},{"value":"Some interference with normal activities","valueDescription":"Some interference with normal activities","ValueMeaning":{"publicId":"4888753","version":"1","preferredName":"Some interference with normal activities","longName":"4888753","preferredDefinition":"Some interference with normal activities","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19ABEEEA-DB11-C2EF-E050-BB89AD43271C","latestVersionIndicator":"Yes","beginDate":"2015-06-29","endDate":null,"createdBy":"LUY","dateCreated":"2015-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19ACAF00-EA34-ED37-E050-BB89AD433698","beginDate":"2015-06-29","endDate":null,"createdBy":"LUY","dateCreated":"2015-06-29","modifiedBy":"ONEDATA","dateModified":"2015-06-29","deletedIndicator":"No"},{"value":"No interference with normal activities of daily living","valueDescription":"No interference with normal activities of daily living","ValueMeaning":{"publicId":"4888715","version":"1","preferredName":"No interference with normal activities of daily living","longName":"4888715","preferredDefinition":"No interference with normal activities of daily living","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19AB6494-D7F4-8836-E050-BB89AD432507","latestVersionIndicator":"Yes","beginDate":"2015-06-29","endDate":null,"createdBy":"LUY","dateCreated":"2015-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19ACAF00-EA3E-ED37-E050-BB89AD433698","beginDate":"2015-06-29","endDate":null,"createdBy":"LUY","dateCreated":"2015-06-29","modifiedBy":"ONEDATA","dateModified":"2015-06-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4888791","version":"1","preferredName":"Injection Site Induration Edema Type","preferredDefinition":"The anatomic site at which a medication or a vaccine is injected.:The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.  This is often associated with inflammation and infiltration of a neoplasm.:Accumulation of an excessive amount of fluid in cells or intercellular tissues.:Something distinguishable as an identifiable class based on common qualities.","longName":"C77680:C25534:C3002:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Injection Site","conceptCode":"C77680","definition":"The anatomic site at which a medication or a vaccine is injected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Induration","conceptCode":"C25534","definition":"The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Edema","conceptCode":"C3002","definition":"Accumulation of an excessive amount of fluid in cells or intercellular tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19ACAF00-E9FA-ED37-E050-BB89AD433698","latestVersionIndicator":"Yes","beginDate":"2015-06-29","endDate":null,"createdBy":"LUY","dateCreated":"2015-06-29","modifiedBy":"ONEDATA","dateModified":"2015-06-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19ACAF00-EA0B-ED37-E050-BB89AD433698","latestVersionIndicator":"Yes","beginDate":"2015-06-29","endDate":null,"createdBy":"LUY","dateCreated":"2015-06-29","modifiedBy":"MAESKEB","dateModified":"2015-10-12","changeDescription":"Created for DCP ylu 06/30/2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4528052","version":"1","longName":"MAY2013-02-01","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"(Swelling) Description of sym","type":"Preferred Question Text","description":"(Swelling) Description of symptoms","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"19ACAF00-EA48-ED37-E050-BB89AD433698","latestVersionIndicator":"Yes","beginDate":"2015-06-29","endDate":null,"createdBy":"LUY","dateCreated":"2015-06-29","modifiedBy":"MAESKEB","dateModified":"2015-10-12","changeDescription":"Created for DCP ylu 06/30/2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}